| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2025 | Aug 11, 2025 | Jazz Pharmaceuticals plc | Director | Sell | 95.0 | +1,702 | 18.63% | ✗ | $200.8K |
| Aug 2, 2024 | Aug 6, 2024 | Jazz Pharmaceuticals plc | Director | Sell | 95.0 | +2,247 | 32.62% | ✗ | $165.2K |
| Jun 6, 2024 | Jun 10, 2024 | Denali Therapeutics Inc. | Director | Sell | 36.3 | -1,458 | -6.78% | ✓ | $31.7K |
| Dec 4, 2023 | Dec 6, 2023 | Jazz Pharmaceuticals plc | Director | Sell | 26.3 | -417 | -5.71% | ✗ | $49.7K |
| Aug 11, 2023 | Aug 15, 2023 | Jazz Pharmaceuticals plc | Director | Sell | 95.0 | +1,834 | 33.52% | ✗ | $171.5K |
| Dec 2, 2022 | Dec 6, 2022 | Jazz Pharmaceuticals plc | Director | Sell | 22.5 | -420 | -7.13% | ✗ | $65K |
| Aug 5, 2022 | Aug 9, 2022 | Jazz Pharmaceuticals plc | Director | Sell | 95.0 | +1,472 | 33.31% | ✗ | $165.9K |
| Dec 2, 2021 | Dec 6, 2021 | Jazz Pharmaceuticals plc | Director | Sell | 22.5 | -417 | -8.62% | ✗ | $50.6K |